The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Lukey, Pauline Teresa, Dr
    Consultant born in December 1955
    Individual (4 offsprings)
    Officer
    2016-02-24 ~ now
    OF - director → CIF 0
    Dr Pauline Teresa Lukey
    Born in December 1955
    Individual (4 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of voting rights - 75% or moreCIF 0
Ceased 1
  • Lukey, David Charles
    Retired born in February 1947
    Individual (3 offsprings)
    Officer
    2016-02-24 ~ 2024-11-29
    OF - director → CIF 0
    Lukey, David
    Individual (3 offsprings)
    Officer
    2016-02-24 ~ 2022-02-13
    OF - secretary → CIF 0
parent relation
Company in focus

TARGET TO TREATMENT (TTT) CONSULTING LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Property, Plant & Equipment
317 GBP2023-02-28
Debtors
20,050 GBP2024-02-29
4,771 GBP2023-02-28
Cash at bank and in hand
45,996 GBP2024-02-29
37,670 GBP2023-02-28
Current Assets
66,046 GBP2024-02-29
42,441 GBP2023-02-28
Net Current Assets/Liabilities
58,037 GBP2024-02-29
40,202 GBP2023-02-28
Net Assets/Liabilities
58,037 GBP2024-02-29
40,519 GBP2023-02-28
Equity
Called up share capital
100 GBP2024-02-29
100 GBP2023-02-28
Retained earnings (accumulated losses)
57,937 GBP2024-02-29
40,419 GBP2023-02-28
Equity
58,037 GBP2024-02-29
40,519 GBP2023-02-28
Average Number of Employees
42023-03-01 ~ 2024-02-29
32022-03-01 ~ 2023-02-28
Property, Plant & Equipment - Gross Cost
Plant and equipment
1,214 GBP2024-02-29
1,214 GBP2023-02-28
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
1,214 GBP2024-02-29
897 GBP2023-02-28
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
317 GBP2023-03-01 ~ 2024-02-29
Property, Plant & Equipment
Plant and equipment
317 GBP2023-02-28
Trade Debtors/Trade Receivables
17,412 GBP2024-02-29
2,133 GBP2023-02-28
Other Debtors
2,638 GBP2024-02-29
2,638 GBP2023-02-28
Trade Creditors/Trade Payables
Amounts falling due within one year
990 GBP2024-02-29
Corporation Tax Payable
Amounts falling due within one year
4,548 GBP2024-02-29
Other Taxation & Social Security Payable
Amounts falling due within one year
1,275 GBP2024-02-29
1,353 GBP2023-02-28
Other Creditors
Amounts falling due within one year
1,196 GBP2024-02-29
886 GBP2023-02-28

  • TARGET TO TREATMENT (TTT) CONSULTING LIMITED
    Info
    Registered number 10023067
    Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2FX
    Private Limited Company incorporated on 2016-02-24 (9 years 4 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-23
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.